4
Changes in Ownership
Evommune, Inc. Filed Acc 0002092017-25-000007
Chief Scientific Officer acquired 3,175 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2025-11-07 | Conversion | +3,175 | 57,091 | D | ||
| Derivatives | |||||||
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2025-11-07 | Conversion · Series B Preferred Stock | −25,000 | 0 | D | ||
Loading xslF345X05/form4-11122025_091148.xml…